STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

BBOT to Participate in the Jefferies Global Healthcare Conference in London

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

BridgeBio Oncology Therapeutics (Nasdaq: BBOT) announced that its leadership team will present at the Jefferies Global Healthcare Conference on Monday, November 17, 2025 at 2:30 p.m. GMT. A live webcast will be available on the company’s Events page at https://investors.bbotx.com/news-events/events. A replay of the webcast will be accessible for at least 90 days after the event.

BridgeBio Oncology Therapeutics (Nasdaq: BBOT) ha annunciato che il suo team dirigente parteciperà al Jefferies Global Healthcare Conference il Lunedì 17 novembre 2025 alle 14:30 GMT. Una trasmissione web dal vivo sarà disponibile nella pagina degli Eventi dell'azienda all'indirizzo https://investors.bbotx.com/news-events/events. Una replica della trasmissione sarà accessibile per almeno 90 giorni dopo l'evento.

BridgeBio Oncology Therapeutics (Nasdaq: BBOT) anunció que su equipo de liderazgo presentará en la Jefferies Global Healthcare Conference el lunes, 17 de noviembre de 2025 a las 2:30 p.m. GMT. Una transmisión en vivo estará disponible en la página de Eventos de la compañía en https://investors.bbotx.com/news-events/events. Una reproducción de la transmisión estará accesible por al menos 90 días después del evento.

BridgeBio Oncology Therapeutics (Nasdaq: BBOT)은 경영진이 제퍼리스 글로벌 헬스케어 컨퍼런스에서 발표할 예정이라고 발표했습니다. 2025년 11월 17일 월요일 오후 2:30 GMT에 개최됩니다. 라이브 웹캐스트는 회사의 이벤트 페이지 https://investors.bbotx.com/news-events/events에서 시청할 수 있습니다. 이벤트 후 최소 90일 동안 웹캐스트 재생을 이용할 수 있습니다.

BridgeBio Oncology Therapeutics (Nasdaq: BBOT) a annoncé que son équipe dirigeante présentera lors de la Jefferies Global Healthcare Conference le lundi 17 novembre 2025 à 14h30 GMT.Une diffusion en direct sera disponible sur la page Événements de l'entreprise à https://investors.bbotx.com/news-events/events. Une rediffusion de la diffusion sera accessible pendant au moins 90 jours après l'événement.

BridgeBio Oncology Therapeutics (Nasdaq: BBOT) hat bekannt gegeben, dass sein Führungsteam auf der Jefferies Global Healthcare Conference am Montag, 17. November 2025 um 14:30 GMT präsentieren wird. Ein Live-Webcast wird auf der Veranstaltungsseite des Unternehmens unter https://investors.bbotx.com/news-events/events verfügbar sein. Eine Wiederholung des Webcasts wird mindestens 90 Tage nach der Veranstaltung zugänglich sein.

BridgeBio Oncology Therapeutics (Nasdaq: BBOT) أعلنت أن فريقها القيادي سيقدم في مؤتمر Jefferies Global Healthcare في الإثنين 17 نوفمبر 2025 الساعة 2:30 م بتوقيت GMT. ستتوفر بث مباشر عبر الويب على صفحة فعاليات الشركة عند https://investors.bbotx.com/news-events/events. ستتوفر إعادة للبث لمدّة لا تقل عن 90 يومًا بعد الحدث.

Positive
  • None.
Negative
  • None.

SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in a presentation at the Jefferies Global Healthcare Conference on Monday, November 17, at 2:30 p.m. GMT.  

A live webcast of the presentation will be accessible on the “Events” page of the BBOT website at https://investors.bbotx.com/news-events/events. A replay of the webcast will be available for at least 90 days following the event.

About BBOT
BBOT is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Kα malignancies. BBOT has the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors. For more information, please visit www.bbotx.com and follow us on LinkedIn.

BBOT Contacts:

Investor Contact:
Heather Armstrong, Head of Investor Relations
BBOT
Investors@BBOTx.com

Media Contact:
Jake Robison
Inizio Evoke Comms
Jake.robison@inizioevoke.com


FAQ

When will BBOT present at the Jefferies Global Healthcare Conference in 2025?

BBOT will present on Monday, November 17, 2025 at 2:30 p.m. GMT.

How can investors watch the BBOT presentation at Jefferies on November 17, 2025?

Watch the live webcast on BBOT’s Events page at https://investors.bbotx.com/news-events/events.

Will there be a replay of the BBOT Jefferies presentation and for how long?

Yes. A replay will be available for at least 90 days following the event.

What topics will BBOT likely cover during the Jefferies Global Healthcare Conference presentation?

Company leadership typically covers corporate updates, clinical program progress, and strategy; expect an overview and program updates.

Is the BBOT presentation at Jefferies on November 17, 2025 open to the public?

Yes. The presentation is accessible via a public live webcast on the company’s Events page.

Where can I find the BBOT webcast if the live event is missed on November 17, 2025?

Access the replay on the same Events page at https://investors.bbotx.com/news-events/events within the 90-day replay window.
Helix Acqsn II

NASDAQ:BBOT

BBOT Rankings

BBOT Latest News

BBOT Latest SEC Filings

BBOT Stock Data

945.61M
59.75M
23.06%
46.39%
0.07%
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON